C
$ Value
$0
Shares
26,191,207
Price
$0
Filed
Oct 30
Insider
Name
Novo Holdings A/S
Title
—
CIK
0001388325
Roles
10% Owner
Transaction Details
Transaction Date
2025-10-28
Code
C
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date. | Represents a purchase from the underwriters in the Issuer's initial public offering.
Filing Info
Novo Holdings A/S's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-28 | MPLT | C | — |
| 2025-10-28 | MPLT | ▲ | $16.2M ★ |
| 2025-10-28 | MPLT | C | $0 |
| 2025-10-28 | MPLT | C | $0 |
Other Insiders at MPLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pavlov George | $441K | — | 2026-02-20 |
| Garnett Timothy John | $253K | — | 2026-02-10 |
|
Kroeger Christopher A.
Chief Executive Officer
|
— | $521K | 2026-04-16 |
|
GILLIS JONATHAN
CAAO and PAO
|
— | $96K | 2026-04-15 |
|
Lillie James Woodruff
Chief Scientific Officer
|
— | $123K | 2026-04-16 |
|
Hanson Kristopher
General Counsel
|
— | $49K | 2026-04-16 |
| Malenka Robert C. | — | $1.6M | 2026-04-15 |
|
Foff Erin Pennock
Chief Medical Officer
|
— | $87K | 2026-04-16 |
|
Kreitzer Anatol
Chief Discovery Officer
|
— | $88K | 2026-04-15 |
|
Setia Vishwas
Chief Financial Officer
|
— | $79K | 2026-04-16 |